CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 279 filers reported holding CYTOKINETICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $515,000 | -29.6% | 10,634 | -90.8% | 0.01% | +600.0% |
| Q4 2018 | $732,000 | -40.0% | 115,762 | -6.5% | 0.00% | -33.3% |
| Q3 2018 | $1,219,000 | +17.0% | 123,767 | -1.4% | 0.00% | 0.0% |
| Q2 2018 | $1,042,000 | +12.5% | 125,547 | -2.4% | 0.00% | +50.0% |
| Q1 2018 | $926,000 | -8.0% | 128,646 | +4.1% | 0.00% | -33.3% |
| Q4 2017 | $1,007,000 | -41.1% | 123,577 | +4.8% | 0.00% | -40.0% |
| Q3 2017 | $1,709,000 | -14.0% | 117,896 | -28.2% | 0.01% | -16.7% |
| Q2 2017 | $1,988,000 | -1.4% | 164,280 | +4.6% | 0.01% | 0.0% |
| Q1 2017 | $2,017,000 | +1.7% | 156,990 | -3.8% | 0.01% | -14.3% |
| Q4 2016 | $1,984,000 | +35.8% | 163,260 | +2.6% | 0.01% | +40.0% |
| Q3 2016 | $1,461,000 | -3.5% | 159,180 | -0.2% | 0.01% | 0.0% |
| Q2 2016 | $1,514,000 | +30.9% | 159,560 | -2.7% | 0.01% | +25.0% |
| Q1 2016 | $1,157,000 | – | 164,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |